---
title: "Kelun Pharma Gets Nod for Trastuzumab; Shares Up 4%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261815335.md"
description: "Kelun Pharma Gets Nod for Trastuzumab; Shares Up 4%"
datetime: "2025-10-20T05:45:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261815335.md)
  - [en](https://longbridge.com/en/news/261815335.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261815335.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/261815335.md) | [繁體中文](https://longbridge.com/zh-HK/news/261815335.md)


# Kelun Pharma Gets Nod for Trastuzumab; Shares Up 4%



### 相关股票

- [KELUN PHARMA (002422.CN)](https://longbridge.com/zh-CN/quote/002422.CN.md)

## 相关资讯与研究

- [Kelun-Biotech Sets March 2026 Board Meeting and Webcast for 2025 Results](https://longbridge.com/zh-CN/news/278713493.md)
- [06:47 ETKelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Atopic Dermatitis](https://longbridge.com/zh-CN/news/278376120.md)
- [Auntea Jenny Schedules Board Meeting to Approve 2025 Results and Consider Final Dividend](https://longbridge.com/zh-CN/news/278853394.md)
- [Qyuns Therapeutics' Arthritis Drug Crusekitug Accepted for Review in China; Shares Jump 11%](https://longbridge.com/zh-CN/news/278491064.md)
- [HSC New Energy Materials Plans Hong Kong Listing; Shares Up 3%](https://longbridge.com/zh-CN/news/278650651.md)